annual FCF:
-$88.27M+$507.24M(+85.18%)Summary
- As of today (July 1, 2025), APLS annual free cash flow is -$88.27 million, with the most recent change of +$507.24 million (+85.18%) on December 31, 2024.
- During the last 3 years, APLS annual FCF has risen by +$475.96 million (+84.36%).
- APLS annual FCF is now -2462.46% below its all-time high of -$3.44 million, reached on December 31, 2013.
Performance
APLS Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$53.42M-$72.76M(-376.20%)Summary
- As of today (July 1, 2025), APLS quarterly free cash flow is -$53.42 million, with the most recent change of -$72.76 million (-376.20%) on March 31, 2025.
- Over the past year, APLS quarterly FCF has increased by +$79.86 million (+59.92%).
- APLS quarterly FCF is now -137.81% below its all-time high of $141.27 million, reached on December 31, 2020.
Performance
APLS quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$8.41M+$79.86M(+90.47%)Summary
- As of today (July 1, 2025), APLS TTM free cash flow is -$8.41 million, with the most recent change of +$79.86 million (+90.47%) on March 31, 2025.
- Over the past year, APLS TTM FCF has increased by +$542.49 million (+98.47%).
- APLS TTM FCF is now at all-time high.
Performance
APLS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
APLS Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.2% | +59.9% | +98.5% |
| 3 y3 years | +84.4% | +52.1% | +98.4% |
| 5 y5 years | +58.5% | +50.9% | +97.5% |
APLS Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.2% | -256.7% | +70.0% | at high | +98.7% |
| 5 y | 5-year | at high | +85.2% | -137.8% | +70.0% | at high | +98.7% |
| alltime | all time | -2462.5% | +85.2% | -137.8% | +70.0% | at high | +98.7% |
APLS Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$53.42M(-376.2%) | -$8.41M(-90.5%) |
| Dec 2024 | -$88.27M(-85.2%) | $19.34M(-43.3%) | -$88.27M(-57.1%) |
| Sep 2024 | - | $34.10M(-504.5%) | -$205.58M(-49.7%) |
| Jun 2024 | - | -$8.43M(-93.7%) | -$408.81M(-25.8%) |
| Mar 2024 | - | -$133.28M(+36.0%) | -$550.90M(-7.5%) |
| Dec 2023 | -$595.51M(+15.6%) | -$97.97M(-42.1%) | -$595.51M(-6.8%) |
| Sep 2023 | - | -$169.13M(+12.4%) | -$639.13M(+2.3%) |
| Jun 2023 | - | -$150.53M(-15.4%) | -$624.61M(+7.4%) |
| Mar 2023 | - | -$177.88M(+25.6%) | -$581.50M(+12.9%) |
| Dec 2022 | -$515.27M(-8.7%) | -$141.59M(-8.4%) | -$515.27M(+6.0%) |
| Sep 2022 | - | -$154.61M(+43.9%) | -$486.19M(-2.9%) |
| Jun 2022 | - | -$107.42M(-3.8%) | -$500.56M(-4.1%) |
| Mar 2022 | - | -$111.65M(-0.8%) | -$522.08M(-7.5%) |
| Dec 2021 | -$564.23M(+240.1%) | -$112.52M(-33.4%) | -$564.23M(+81.7%) |
| Sep 2021 | - | -$168.98M(+31.1%) | -$310.44M(+26.7%) |
| Jun 2021 | - | -$128.94M(-16.2%) | -$245.03M(+16.2%) |
| Mar 2021 | - | -$153.80M(-208.9%) | -$210.92M(+27.1%) |
| Dec 2020 | -$165.91M | $141.27M(-236.4%) | -$165.91M(-57.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$103.56M(+9.2%) | -$389.40M(+14.6%) |
| Jun 2020 | - | -$94.83M(-12.8%) | -$339.91M(+19.2%) |
| Mar 2020 | - | -$108.78M(+32.3%) | -$285.18M(+34.0%) |
| Dec 2019 | -$212.83M(+62.2%) | -$82.23M(+52.1%) | -$212.83M(+21.6%) |
| Sep 2019 | - | -$54.07M(+34.8%) | -$175.08M(+13.6%) |
| Jun 2019 | - | -$40.10M(+10.1%) | -$154.14M(+6.5%) |
| Mar 2019 | - | -$36.44M(-18.1%) | -$144.74M(+10.3%) |
| Dec 2018 | -$131.24M(+181.7%) | -$44.48M(+34.2%) | -$131.24M(+28.3%) |
| Sep 2018 | - | -$33.13M(+7.9%) | -$102.30M(+27.4%) |
| Jun 2018 | - | -$30.69M(+33.8%) | -$80.30M(+31.4%) |
| Mar 2018 | - | -$22.94M(+47.7%) | -$61.10M(+31.1%) |
| Dec 2017 | -$46.60M(+79.2%) | -$15.53M(+39.5%) | -$46.60M(+50.0%) |
| Sep 2017 | - | -$11.14M(-3.1%) | -$31.06M(+55.9%) |
| Jun 2017 | - | -$11.50M(+36.4%) | -$19.92M(+136.4%) |
| Mar 2017 | - | -$8.43M | -$8.43M |
| Dec 2016 | -$26.00M(+37.9%) | - | - |
| Dec 2015 | -$18.86M(+89.2%) | - | - |
| Dec 2014 | -$9.97M(+189.3%) | - | - |
| Dec 2013 | -$3.44M | - | - |
FAQ
- What is Apellis Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual FCF year-on-year change?
- What is Apellis Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly FCF year-on-year change?
- What is Apellis Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM FCF year-on-year change?
What is Apellis Pharmaceuticals annual free cash flow?
The current annual FCF of APLS is -$88.27M
What is the all time high annual FCF for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual free cash flow is -$3.44M
What is Apellis Pharmaceuticals annual FCF year-on-year change?
Over the past year, APLS annual free cash flow has changed by +$507.24M (+85.18%)
What is Apellis Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of APLS is -$53.42M
What is the all time high quarterly FCF for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly free cash flow is $141.27M
What is Apellis Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, APLS quarterly free cash flow has changed by +$79.86M (+59.92%)
What is Apellis Pharmaceuticals TTM free cash flow?
The current TTM FCF of APLS is -$8.41M
What is the all time high TTM FCF for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM free cash flow is -$8.41M
What is Apellis Pharmaceuticals TTM FCF year-on-year change?
Over the past year, APLS TTM free cash flow has changed by +$542.49M (+98.47%)